HIV Risks Among Injection Drug Using Populations: Past, Present, and Projections for the future Steffanie A. Strathdee (1) Timothy B. Hallett (2) Natalia.

Slides:



Advertisements
Similar presentations
HIV in Europe Stockholm, 3.November 2009 Communication on combating HIV/AIDS in the EU and the neighbourhood - strategy and second action plan ( )
Advertisements

Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Police Brutality is Independently Associated with Sharing Injection Equipment among Injection Drug Users in Odessa, Ukraine Supported by the National Institute.
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
Attaining Realistic and Substantial Reductions in HIV Incidence: Model Projections of Combining Microbicide and Male Circumcision interventions in Rural.
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
The Global Epidemiology of HIV among Female Sex Workers: The Influence of Structural Determinants Shannon K, Strathdee SA, Goldenberg S, Duff P, Mwangi.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
Public Funding of Syringe Exchange in the US: The Challenges of Failures and Successes and the New Heroin Injectors Don Des Jarlais 1, Heidi Bramson 1,
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
People left behind: People living with HIV
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,
Harm Reduction.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University.
A Review of Barriers and Ways Forward Daniel Wolfe 1 Patrizia Carrieri 2 Donald Shepard 3 Paper 3 Treatment and Care for IDUS with HIV 1. Open Society.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Papua New Guinea Last updated: July 2015.
1 People who use drugs, HIV, and human rights The Lancet : HIV in people who use drugs Vienna, 20 July 2010 Ralf Jürgens Joanne Csete, Joe Amon Steven.
What impact could we expect at a community level from an effective rectal microbicide used by MSM in Peru? HJ Prudden, HC Johnson, AM Foss, J Peinado,
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
HIV vulnerabilities of sex workers in Europe
The investment framework - Critical enablers are not a luxury! Bernhard Schwartlander.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
The U.S. President’s Emergency Plan for AIDS Relief Title Cost and Impacts of expanding male circumcision services in Eastern and Southern Africa Emmanuel.
India Last updated: January 2016.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
HIV/AIDS in Eastern Europe Setting the Stage for Prevention HIV/AIDS in Eastern Europe Setting the Stage for Prevention Thomas E. Novotny, MD, MPH April.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
HIV/AIDS IN AFRICA- "The Orphaned Continent"
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS H HIV Prevention for Female Sexual Partners of People Who Inject Drugs: Evaluation Results Theodore.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
Zindoga Mukandavire Social and Mathematical Epidemiology Group London School of Hygiene and Tropical Medicine, UK Improving health worldwide
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Incarceration and People Who Inject Drugs in Ukraine: Modelling its Role in HIV Transmission and the Impact of Introducing OST in Prisons Jack Stone, Ellen.
Injecting Drug Users and HIV/AIDS in Pakistan
The analysis and advocacy (A2) project: Role in translating Thailand’s national AIDS strategy into provincial implementation plans S. Pantuwatana1, S.
Pakistan Last updated: July 2015.
Addressing Drug Use Together Through a Health Based Approach:
Modeling the potential impact of providing ART and OAT in prison and upon release on HIV incidence among PWID in Tijuana, Mexico Add other affiliations.
Modeling the impact of the Mexican drug law reform on HIV incidence among people who inject drugs (PWID) in Tijuana, Mexico. Add other affiliations for.
Coverage of HIV and HCV prevention interventions for people who inject drugs Dr Sarah Larney, Senior Research Fellow.
Edward Mbizo Sibanda, (MSc) Right to Care
The HIV Epidemic among People who Inject Drugs
Myanmar Last Update: November 2014.
No conflicts of interest
Presentation transcript:

HIV Risks Among Injection Drug Using Populations: Past, Present, and Projections for the future Steffanie A. Strathdee (1) Timothy B. Hallett (2) Natalia Bobrova (3) Tim Rhodes (4) Robert Booth (5) Reychad Abdool (6) Catherine Hankins (7) ( 1) University of California San Diego, Department of Medicine, CA, USA (2) Imperial College London, London, United Kingdom (3) University College London, United Kingdom (4) London School of Hygiene & Tropical Medicine, University of London, UK (5) University of Colorado at Denver, CO, USA (6) UNODC, Regional Office for Eastern Africa, Kenya (7) Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland 2010 Funding: NIDA R01DA S1 & DA17620; Office of AIDS Research Wellcome Trust

The HIV risk environment Levels: – Macro – Micro Types: – Physical – Social – Economic – Policy Adapted from Rhodes 1999 and Glass and McAttee 2006

1) Review research on HIV risk factors among IDUs over the last decade To what extent is this literature consistent with the risk environment framework? 2) Illustrate how varying levels of environmental influence affect IDUs’ risk behaviours, HIV incidence and attributable risks in 3 citiesObjectives

2,722 documents collected from peer-reviewed literature 146 documents selected after reviewing title, keywords, abstracts 94 documents with data on risk factors, correlates, determinants Only 25% aimed to identify at least one micro- or macro- level environmental determinant, but 86% nevertheless did so Review of HIV epidemiology literature among IDUs:

Results of Review Over the past decade: Only 31% of studies were conducted in countries with high HIV burdens among IDUs. Most studies identified: Micro- rather than macro-level influences Physical and social rather than economic or policy influences Future studies should draw from social science literature, using a mixed methods approach

-How HIV epidemics may continue with and without future changes in proximate determinants of HIV risk in 3 cities: Modelling Scenarios Odessa, UkraineKarachi, PakistanNairobi, Kenya HIV epidemic among IDUs Established Emerging HIV epidemic among population GeneralizedConcentratedGeneralized Change in proximate determinant Police brutality (associated with needle sharing) Transition from non-injection to injection drug use Law prohibiting opioid substitution therapies (OST)

Inadequate ART provision and Sexual transmission can play key roles in some IDU-related epidemics Karachi Odessa

Impact of Scaling up Combination HIV Interventions: Example from Odessa Reducing unmet need of OST, NSP and ART by 60% could prevent 41% of incident HIV infections

Need to Optimize Intervention Coverage and Efficacy when Force of Infection is High: Nairobi Need to Optimize Intervention Coverage and Efficacy when Force of Infection is High: Nairobi

8-12% reduction in transition from non-injecting to injecting could prevent 65–98% of incident HIV infections in Karachi Local HIV epidemics are sensitive to different types of structural changes: Karachi

Eliminating laws prohibiting OST and scaling up NSP and OST to 80% coverage could prevent 29% of new HIV infections among IDUs in Nairobi by 2015

Conclusions HIV epidemics among IDUs can be significantly curtailed if interventions are: -Evidence and Rights-based -Including scale up of OST, NSP and ART - Take into account local risks operating at multiple levels of influence Structural HIV prevention interventions are a crucial element of a combination prevention approach Shifts responsibility for change away from individuals, towards social/political contexts.

Acknowledgements Study Coauthors Drs. Hallett, Bobrova, Rhodes, Booth, Abdool, Hankins Reviewers (incl. D. Burrows, P. Vickerman, G. Stimson, R.White) US National Institute on Drug Abuse grants: -R01 DA S1, R01 DA17620 Office of AIDS Research The Wellcome Trust (UK)

Christy Anderson Richard Armenta Annick Borquez Philippe Bourgois David Celentano Jessica Cubeta Penny Coppernoll-Blach Anna Dovbahk Faran Emmanuel Samuel R. Friedman Micah Gell-Redman Eleanor Gouws Mauro Guarinieri Peter Hartsock Brian Houle Francisco Inacio Bastos Natalia Kitsenko Acknowledgments Carl Latkin Robert Malow Bradley Mathers Lisovska Oksana Jane Marie Ongo’lo Samiran Panda Natalia Rehtina Diana Rossi Richard Rothenberg Tatyana Saliuk Oleg Semeryk Ani Shakarishvili Alexandra Thomas Emily To Lucas Wiessing Daniel Wolfe

Extra Slides

Example: HIV infections averted by eliminating Police Beatings in Three Cities in Ukraine Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Model projection, Odessa Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Projected number of HIV infections, , Odessa Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Estimated attributable risk, , Odessa Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Number of HIV infections among IDUs, , Karachi Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Model projections, Karachi Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Projected number of HIV infections, , Karachi Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Estimated attributable risk, , Karachi Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Number of HIV infections among IDUs, , Karachi Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Projected number of HIV infections, Kenya Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Number of HIV infections in IDUs, , Kenya Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Databases searched: BIOSIS (ISI-CE Biosis previews), PubMed, and EMBASE for the period 2000 to 2009 Search components: 1."HIV"OR "HIV Infections“ or “HIV” or “AIDS” or "human immunodeficiency virus" or "acquired immunodeficiency syndrome" or "acquired immune deficiency syndrome" 2."Substance Abuse, Intravenous“ or “IDU” or “IDUs” or "injecting drug" or "intravenous drug" or "intravenous substance" or "injecting substance" or “injecting drug use” 3.“Risk factor” or “correlate” or “determinant” Search criteria Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Physical risk factors: Summary of HIV risks among IDUs according to the risk environment framework* ( ) Micro-environmentCitationsMacro-environmentCitations Drug injecting locations 57–67 Drug trafficking and distribution routes Homelessness 67–73 Trade routes and population mobility 74 Prisons and incarceration 63,64,69,71,75–82 Geographical population shifts, neighbourhood and population mixing 83,84 Exposure to violence, trauma 84 Deportation 85 Spatial inequalities 5,40,58,71,85–95 Distance from HIV epicenter 96 Location of recruitment 83 *adapted from Rhodes and Simic, 2005 (12) (will seek appropriate permissions) Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Social risk factors: Summary of HIV risks among IDUs according to the risk environment framework* ( ) Social and peer group norms Gender inequalities and gendered risk 75,90,94,97–100 Relationship/network dynamics 5,40,57,71,73,79,80,85,86,90,91,91,94,101–115 Stigmatization and marginalization of drug users Sexuality and sexual orientation ,66,83,99,109,111,115–120 Weak civil society and community advocacy Local policing practices and ‘crackdowns’ 85,94,121 Police per capita 121 Community health and welfare service access and delivery 99 Exposure to war/conflict/disasters Education 57,61,66,71,100 Ethnic/racial inequities 59,69,70,72,89– 91,109,112– 114,120,122,122–126 Drugs easy to obtain 112 Peer outreach 127 *adapted from Rhodes and Simic, 2005 (12) (will seek appropriate permissions) Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Economic risk factors: Summary of HIV risks among IDUs according to the risk environment framework* ( ) Cost of living and of health treatments Lack of health service revenue and spending Cost of syringes Correction Expenditures 121 Cost of condoms Growth of informal economies Lack of income generation and employment 61,77,82,95,102,103,109,128,129 Uncertain economic transition Survival sex trade/sex work 59,103,106,109,111,115, 117,130 *adapted from Rhodes and Simic, 2005 (12) (will seek appropriate permissions) Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

Policy risk factors: Summary of HIV risks among IDUs according to the risk environment framework* ( ) Coverage of sterile needles and syringes 131,132 Policy and laws governing syringe access and exchange – and enforcement status 123 Coverage of drug treatment 61,69,103,104,112,130,132, 133 Policy and laws governing drug treatment Coverage of HIV testing and Counselling 118 Policy and laws governing free HAART coverage Coverage of HAART 72 Public health policy governing sex work -- and enforcement status Program-level policies governing distribution of injection equipment Laws governing possession of drugs and drug paraphernalia – and enforcement status 96,134 Access to low-threshold and social housing Immigration policies and laws Laws governing protection of human and health rights *adapted from Rhodes and Simic, 2005 (12) (will seek appropriate permissions) Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.

1.Abstracts examined to determine eligibility for inclusion 2.Search included all languages 3.Excluded manuscripts where: -HIV infection was not an outcome, -no primary data presented, -data on IDUs not presented separately -manuscripts were commentaries, editorials or reviews 4.Data extracted by two independent reviewers and entered into a systematic coding form 5.Random 10% verified by a third reviewer 6.Coded data mapped onto various levels and types of environmental influence according to the risk environment framework Search methods Strathdee SA, Hallett TB, Bobrova N, et al. HIV and the Risk Environment among People Who Inject Drugs: Past, Present, and Projections for the Future. Lancet. In press.